JP2005526808A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526808A5
JP2005526808A5 JP2003579830A JP2003579830A JP2005526808A5 JP 2005526808 A5 JP2005526808 A5 JP 2005526808A5 JP 2003579830 A JP2003579830 A JP 2003579830A JP 2003579830 A JP2003579830 A JP 2003579830A JP 2005526808 A5 JP2005526808 A5 JP 2005526808A5
Authority
JP
Japan
Prior art keywords
compound
formula
rhinitis
asthma
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003579830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526808A (ja
Filing date
Publication date
Priority claimed from GBGB0207432.6A external-priority patent/GB0207432D0/en
Application filed filed Critical
Publication of JP2005526808A publication Critical patent/JP2005526808A/ja
Publication of JP2005526808A5 publication Critical patent/JP2005526808A5/ja
Pending legal-status Critical Current

Links

JP2003579830A 2002-03-28 2003-03-27 炎症状態の治療においてccr−3拮抗薬として使用するためのモルホリン尿素誘導体のベンゼンスルホン酸塩 Pending JP2005526808A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207432.6A GB0207432D0 (en) 2002-03-28 2002-03-28 Novel compounds
PCT/EP2003/003345 WO2003082293A1 (en) 2002-03-28 2003-03-27 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions

Publications (2)

Publication Number Publication Date
JP2005526808A JP2005526808A (ja) 2005-09-08
JP2005526808A5 true JP2005526808A5 (enExample) 2006-05-18

Family

ID=9933984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003579830A Pending JP2005526808A (ja) 2002-03-28 2003-03-27 炎症状態の治療においてccr−3拮抗薬として使用するためのモルホリン尿素誘導体のベンゼンスルホン酸塩

Country Status (22)

Country Link
US (1) US7531651B2 (enExample)
EP (1) EP1487456B1 (enExample)
JP (1) JP2005526808A (enExample)
KR (1) KR20040099375A (enExample)
CN (1) CN1642554A (enExample)
AR (1) AR039179A1 (enExample)
AT (1) ATE317698T1 (enExample)
AU (1) AU2003226761A1 (enExample)
BR (1) BR0308480A (enExample)
CA (1) CA2479912A1 (enExample)
DE (1) DE60303603T2 (enExample)
ES (1) ES2258724T3 (enExample)
GB (1) GB0207432D0 (enExample)
IL (1) IL163847A0 (enExample)
IS (1) IS7432A (enExample)
MX (1) MXPA04009456A (enExample)
NO (1) NO20044323L (enExample)
PL (1) PL372623A1 (enExample)
RU (1) RU2004126948A (enExample)
TW (1) TW200407145A (enExample)
WO (1) WO2003082293A1 (enExample)
ZA (1) ZA200407463B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140335083A1 (en) * 2011-12-01 2014-11-13 Glaxo Group Limited Methods of treatment and prevention of eye diseases
FR3022142B1 (fr) 2014-06-16 2019-07-12 Universite Paul Sabatier - Toulouse Iii Inhibition de la chimiokine ccl7 ou de son recepteur ccr3 pour le traitement et le diagnostic du cancer de la prostate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031431A1 (en) 1994-05-18 1995-11-23 Nisshin Flour Milling Co., Ltd. Novel diaminomethylidene derivative
BR9915520A (pt) 1998-11-20 2001-07-17 Hoffmann La Roche Antagonistas receptores ccr-3 derivados de pirrolidina
IL155092A0 (en) 2000-09-29 2003-10-31 Glaxo Group Ltd Compounds useful in the treatment of inflammatory diseases

Similar Documents

Publication Publication Date Title
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2021063088A5 (enExample)
JP2006182786A5 (enExample)
JP2006526590A5 (enExample)
JP2007505877A5 (enExample)
JP2007502804A5 (enExample)
JP2008509187A5 (enExample)
JP2007533722A5 (enExample)
JP2008521827A5 (enExample)
JP2007507494A5 (enExample)
RU2004126610A (ru) Селективные дипетидные ингибиторы калликреина
JP2009526821A (ja) 注意欠陥多動性障害治療用の新規な医薬組成物
CN1711085A (zh) 含乙酸酰基苯胺衍生物作为活性成分的膀胱活动过度的治疗药物
JP2006507220A5 (enExample)
JP2010522710A5 (enExample)
JP2003519228A5 (enExample)
JP2005517677A5 (enExample)
JP2005532397A5 (enExample)
JP2005500370A5 (enExample)
JP2004510750A5 (enExample)
JP2005537262A5 (ja) 皮膚疾患を局所的に治療するための医薬品
JP2004525178A5 (enExample)
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
JP2013544794A5 (enExample)
JP2004538314A5 (enExample)